Revisi per 9 Mei 2024 16.50 sunting Muhammad Anas Sidik (bicara \| kontrib) 26.765 suntingan Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan ← Revisi sebelumnya		Revisi per 9 Mei 2024 16.57 sunting balikkan Muhammad Anas Sidik (bicara \| kontrib) 26.765 suntingan →Farmakodinamik Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan Revisi selanjutnya →
Baris 220: {\| class="wikitable" \|+ Ikhtisar target dan efek difenhidramin ~~\|+ Overview of diphenhydramine targets and effects~~ \|- ! ~~Biological~~Target ~~target~~biologi !! Mode ~~of action~~aksi !! ~~Effect~~Efek \|- \| ~~[[Histamine~~Reseptor ~~H1 receptor\|~~H<sub>1</sub> ~~receptor]]~~ \|\| ~~[[Inverse~~Agonis ~~agonist]]~~terbalik \|\| ~~[[Antihistamine\|Allergy~~Pengurangan ~~reduction]]~~alergi; ~~[[Sedative\|Sedation]]~~Sedasi \|- \| Reseptor asetilkolin muskarinik \|\| Antagonis \| [[Muscarinic acetylcholine receptor\|{{abbr\|mACh\|Muscarinic acetylcholine}} receptor]]s \|\| [[Competitive antagonist\|Antagonist]] \|\| [[Anticholinergic syndrome\|Anticholinergic]]; [[Management of Parkinson's disease#Medication\|Antiparkinson]] \|\| [[Antikolinergik]]; Antiparkinson \|- \| Saluran natrium \|\| Penghambat \|\| [[Anestesi lokal]] ~~\| [[Voltage-gated sodium channel\|Sodium channel]]s \|\| [[Ion channel#Ion channel blockers\|Blocker]] \|\| [[Local anesthetic]]~~ \|}

Difenhidramin: Perbedaan antara revisi